Propofol Regulates ER Stress to Inhibit Tumour Growth and Sensitize Osteosarcoma to Doxorubicin

Osteosarcoma is the most common malignant bone tumour affecting children and young adults. The antitumour role of propofol, a widely used intravenous sedative-hypnotic agent, has been recently reported in different cancer types. In this study, we aimed to assess the role of propofol on osteosarcoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Hua, Du, Xinhui, Zhao, Huaping, Sun, Peipei, Yang, Jianjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897936/
https://www.ncbi.nlm.nih.gov/pubmed/36756222
http://dx.doi.org/10.1155/2023/3093945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897936/
https://www.ncbi.nlm.nih.gov/pubmed/36756222
http://dx.doi.org/10.1155/2023/3093945

Ejemplares similares